Pure Global

Early Bowel Resection for Terminal Ileal Crohn's Disease - Trial NCT06116604

Access comprehensive clinical trial information for NCT06116604 through Pure Global AI's free database. This phase not specified trial is sponsored by Sheffield Teaching Hospitals NHS Foundation Trust and is currently Recruiting. The study focuses on Crohn Disease. Target enrollment is 496 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06116604
Recruiting
Trial Details
ClinicalTrials.gov โ€ข NCT06116604
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Early Bowel Resection for Terminal Ileal Crohn's Disease
Early Bowel Resection for Terminal Ileal Crohn's Disease - Exploring Patients' and Clinicians' Perspectives and Barriers to Implementation

Study Focus

Crohn Disease

Observational

Sponsor & Location

Sheffield Teaching Hospitals NHS Foundation Trust

Sheffield, United Kingdom

Timeline & Enrollment

N/A

Sep 07, 2023

Nov 30, 2025

496 participants

Primary Outcome

Themes,Trade off preferences for treatments,Patient preference for timing of resection,Decision-regret

Summary

The goal of this multicentre mixed -methods study is to understand the patient and clinician
 perspective on the ideal timing of an operation for Crohn's disease of the terminal ileum
 (last part of the small bowel). The main questions it aims to answer are:
 
 - What factors influence patients' and clinicians' preferences with regards to the timing
 of the first bowel resection for isolated Crohn's disease of the terminal ileum?
 
 - What are patients' and clinicians' views on 'early' bowel resection (as an alternative
 to medical therapy) in this context?
 
 - What are the facilitators and barriers to implementation of early surgery in practice?
 
 Participants will be patients with Crohn's disease of the terminal ileum and healthcare
 professionals involved in treating inflammatory bowel disease.
 
 Healthcare professionals have previously been asked to participate in an interview to
 understand their views on the role of surgery for Crohn's disease of the terminal ileum. They
 will now be invited to participate in a choice exercise to understand how much weight they
 attribute to various factors and outcomes when choosing between surgery and medication for
 Crohn's disease of the terminal ileum.
 
 Patients will be asked to participate in:
 
 1. an interview about their treatment choices
 
 2. a choice exercise to understand how much weight they attribute to various factors and
 outcomes when choosing between surgery and medication for Crohn's disease of the
 terminal ileum
 
 3. a survey, for patients with a previous ileocaecal resection, assessing their experience
 of the operation

ICD-10 Classifications

Crohn disease, unspecified
Other Crohn disease
Crohn disease of large intestine
Crohn disease of small intestine
Crohn disease [regional enteritis]

Data Source

ClinicalTrials.gov

NCT06116604

Non-Device Trial